← SynDRA
LENACAPAVIR
SynDRA canonical compound SYN0040063 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | hiv capsid assembly inhibitor |
| Indication | human immunodeficiency virus (hiv-1) |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- hiv capsid assembly inhibitor
- Inhibitor
- gag INHIBITOR
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- lenacapavir sodium
- sunlenca
- GS-HIV
- GS-6207
- GS-CA-2
- GS-CA2
- GS-714207
- GS-CA1
- GS6207
- N-[(1R)-1-[3-[4-Chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-6-(3-methyl-3-methylsulfonylbut-1-ynyl)pyridin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2R,4S)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide
- A9A0O6FB4H
- RefChem:58516
- Lenacapavir [USAN]
- Yeztugo
- QNG
- LENACAPAVIR [INN]
- Lenacapavir (USAN/INN)
- UNII-A9A0O6FB4H
- Lenacapavir(GS-6207)?
- LENACAPAVIR [WHO-DD]
- orb1309612
- SCHEMBL19875642
- SCHEMBL29398353
- SCHEMBL29412122
- SCHEMBL30892008
- GTPL11446
- Yeztugo (twice-yearly injection)
- BRYXUCLEHAUSDY-WEWMWRJBSA-N
- CHEBI:234519
- GLXC-21385
- EX-A5518
- WHO 11108
- AKOS040733301
- AT20076
- EBC-2690076
- AC-37536
- DA-73883
- MS-31818
Look up LENACAPAVIR in the interactive SynDRA portal →